Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease

Tapered oral dexamethasone for acute chest syndrome (ACS) in sickle cell anaemia was studied using a novel ACS assessment tool and investigational biomarkers. Twelve participants were randomized (mean age 17.3 years) before early study termination. Dexamethasone decreased duration of hospitalization...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Quinn, Charles T., Stuart, Marie J., Kesler, Karen, Ataga, Kenneth I., Wang, Winfred C., Styles, Lori, Smith-Whitley, Kim, Wun, Ted, Raj, Ahsok, Hsu, Lewis L., Krishnan, Suba, Kuypers, Frans A, Setty, B. N. Yamaja, Rhee, Seungshin, Key, Nigel S., Buchanan, George R.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3368951/
https://ncbi.nlm.nih.gov/pubmed/21848879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2011.08827.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items